All4NutraNo products in the cart.
All4NutraStartseite » Oral Excipients » Page 25
Abstract Optical coherence tomography (OCT) has emerged as an in-line monitoring technique for pharmaceutical coating processes based on a representative...
Abstract Gastrointestinal disorders originate in the gastrointestinal tract (GIT), and the therapies can benefit from direct access to the GIT...
Developing a formulation for the oral route is a long and complex journey in which the API (Active Pharmaceutical Ingredient)...
From optimized gastric resistance to enhanced bioavailability - EUDRACAP® leverages the functional versatility and safety of EUDRAGIT® to solve key...
Abstract Purpose of review Herein, we present an overview of innovative oral technologies utilized in colonic drug delivery systems that...
Press Release Health Care, Essen, Germany, September 25, 2024 EUDRACAP® colon is the only functional, ready-to-fill capsule on the market...
Pharmaceutical lactose has been used since the 19th century, and has carved out a place for itself in the pharmaceutical...
Abstract Aim: Dasatinib (DST) is an oral tyrosine kinase inhibitor with poor aqueous solubility. To outwit this issue, a solid self-nano...
This research aims to produce orodispersible films (ODFs) and determine their potential use in the oral delivery of montelukast sodium...
Diabetes is a long-term metabolic disorder caused by issues with insulin production or response in the body. This leads to...
Copyright: PharmaExcipients AG